Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with…
Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined…